Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
US6140335A · kind A · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 1999 |
| Grant date | Oct 31, 2000 |
| Priority date | — |
| Expiry date | Nov 19, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of mizolastine and the pharmaceutically acceptable salts thereof for making a medicine for treating inflammatory diseases or inflammatory constituents of some other diseases related to the 5-lipoxygenase route.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.